Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
Yes, both will likely be more expensive
Tirzepatide extreme appetite suppression can exacerbate disordered eating patterns and may be psychologically harmful for individuals with active eating disorders
This helps you feel fuller for a longer period after eating
Final Thoughts GLP-1 drugs like Ozempic and Wegovy are powerful tools for weight loss and diabetes managementbut they are not risk-free
